Schedule 13D ownership disclosure
NANO DIMENSION LTD
Ordinary Shares, par value NIS 5.00 per share · CUSIP: 63008G203
Event date: 2026-02-17
- Filing-level shares
- 10,942,087.00
- Percent of class
- 5.2%
- Oramed Pharmaceuticals Inc.Reported CIK 0001176309
Shares: 10,942,087.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-018576
- Form type
- SCHEDULE 13D/A
- Filer
- Nano Dimension Ltd.
- CIK
- CIK 1643303
- Filed
- Feb 19, 2026
- Reporting period
- Feb 17, 2026
- Description
- Schedule 13D beneficial ownership